Pfizer Starts Mid-To-Late-Stage Study Testing Oral Antiviral For Prevention Of COVID-19 Infection

Reuters (9/27, Maddipatla, Khandekar, Chandra Eluri) reports that on Monday, Pfizer Inc announced that “it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have...